The Bangalore-based pharma company Strides Arcolab’s subsidiary, Agila Specialties, will launch a range of injectable generic drugs in Canada.
This will be done through a joint venture with Canadian company Jamp Pharma; Agila will hold 70 per cent stake in the new company Agila-Jamp Canada Inc.
The new venture will launch 40 products in the next two years, the company said in a statement to the BSE.
“Many of the products will be immediately launched through local hospitals and pharmacists, and the existing sales force at Jamp Pharma will be responsible for introducing the entire Agila-Jamp product portfolio,” the company said in the statement.